Seegene Introduces Innovative Solutions for mpox Detection
In a significant step forward for public health, Seegene Inc. has unveiled its latest product, the Novaplex™ MPXV/OPXV plus Assay. This state-of-the-art research-use-only (RUO) assay is specifically designed to identify and detect the mpox virus, particularly the more transmissible and deadly Clade I, which poses greater risks than Clade II.
Enhanced Accuracy with the New Assay
Distinctive Features of the Novaplex™ Assay
The Novaplex™ MPXV/OPXV plus Assay can accurately detect non-variola Orthopoxvirus (OPXV) along with the mpox virus (MPVX). Importantly, it confirms MPXV Clade I infections with high precision, providing essential support to healthcare professionals in their research, especially amidst the ongoing challenges posed by the spread of mpox.
Compliance with International Health Standards
Aligned with the World Health Organization's (WHO) target product profiles, Seegene's latest assay ensures accurate detection of viral strains. By following these guidelines, the assay helps healthcare professionals identify new mpox cases with precision, thereby contributing effectively to global health initiatives.
Global Health Response Efforts
Seegene has taken a proactive stance in tackling the recent global public health crisis related to mpox. The WHO has categorized the mpox outbreak as a Public Health Emergency of International Concern (PHEIC), prompting Seegene to create two new assays aimed at meeting urgent global health needs.
Alongside the Novaplex™ MPXV/OPXV Assay (RUO), the company has also developed the Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO), which detects four viruses simultaneously, including mpox and various strains of the herpes virus. Both assays meet WHO criteria, ensuring that researchers have the necessary tools to effectively address the spread of these viruses.
Dedication to Addressing the Spread of mpox
Daniel Shin, Seegene’s Executive Vice-President and Chief Global Sales and Marketing Officer, emphasized the company’s commitment to combating the mpox virus. "As we observe the ongoing spread of mpox, we are ramping up our efforts to develop RUO assays that meet the urgent research needs of affected countries,” he stated.
The Wider Implications of mpox
To put the current situation into perspective, the Africa Centres for Disease Control and Prevention has reported concerning figures from January to September 2024, with over 24,851 suspected cases and 5,549 confirmed cases. This highlights the critical need for effective detection methods.
Moreover, mpox is spreading beyond its usual regions, with cases now reported in countries such as Sweden, Pakistan, and Thailand. This global expansion emphasizes the urgent necessity for advanced detection solutions.
About Seegene
With over 23 years of experience in research, development, and manufacturing focused on multiplex PCR technologies, Seegene has gained international recognition. Their capabilities were particularly highlighted during the pandemic, allowing them to provide over 340 million COVID-19 tests to more than 100 countries. Seegene’s technology, which enables simultaneous testing for multiple pathogens, is crucial for addressing global health challenges.
Frequently Asked Questions
What is the Novaplex™ MPXV/OPXV plus Assay?
The Novaplex™ MPXV/OPXV plus Assay is a new PCR assay designed to detect mpox Clade I and other Orthopoxviruses to support research efforts globally.
Why is mpox Clade I concerning?
MPXV Clade I poses higher transmission and mortality risks compared to other variants, making accurate detection critically important.
How does Seegene's assay help healthcare professionals?
By adhering to WHO standards and accurately diagnosing infections, the assay provides healthcare professionals necessary insights for managing outbreaks.
What other products have been developed by Seegene?
In addition to the new mpox assays, Seegene also offers assays that test for herpes simplex viruses, significantly broadening the scope of their research utility.
What is Seegene's experience in diagnostics?
With decades of experience, Seegene is recognized for its advanced PCR technology and for delivering millions of tests to tackle global health crises effectively.